Why the study?
Does transcatheter radiofrequency ablation of the right bundle branch prevent recurrent ventricular tachycardia in patients with bundle-branch reentry?
Does transcatheter radiofrequency ablation of the right bundle branch prevent recurrent ventricular tachycardia in patients with bundle-branch reentry?
Transcatheter radiofrequency ablation of the right bundle branch is highly effective at eliminating bundle-branch reentry ventricular tachycardia, with no recurrences observed during long-term follow-up.
Right bundle branch ablation may prevent recurrent bundle-branch reentry VT; leaves open need for prospective trials before practice change.
We have identified bundle-branch reentry (BBR) as the mechanism of ventricular tachycardia (VT) during electrophysiologic studies in 48 patients at our institution. All but three patients had significant structural heart disease, that is, dilated ischemic or idiopathic cardiomyopathy, the most common of anatomic substrates. Syncope and sudden death were the modes of presentation in up to 70% of these patients. The critical prerequisite for the development of this arrhythmia is conduction delay in the His-Purkinje system, which was present in all patients and manifests as a nonspecific conduction delay or a left bundle-branch block (LBBB) in the surface electrocardiogram (ECG) and a prolonged HV interval in the intracardiac recordings. VT with an LBBB morphology is the most common form of BBR, present in 98% of patients. Transcatheter ablation of the right bundle branch (RBB) with the use of radiofrequency current is the treatment of choice, as it effectively eliminates BBR. During long-term follow-up, recurrent tachycardia due to BBR was not documented in any patient; however, congestive heart failure was a common cause of death in this population.
No takes yet. Share an insight, caveat, or question.
Blanck et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: